Why insider trading matters?

If management teams do not own any relevant stakes in the companies they guide, they may not be focused on creating wealth for shareholders to the same degree, compared to those that see their personal wealth increase when share prices rise.

- Klaus Gugler, Economist
Summit Therapeutics Inc. (SMMT)
Sector: Healthcare; Industry: Biotechnology

Summit Therapeutics plc, a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States, Latin America, and Europe. It conducts clinical programs focusing on the Clostridium difficile infection (CDI). The company was formerly known as Summit Corporation plc and changed its name to Summit Therapeutics plc in February 2015. Summit Therapeutics plc was founded in 2003 and is based in Abingdon, the United Kingdom.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-05-12 DUGGAN ROBERT W Chief Executive Officer Buy 11,365,921 $5.24 $59,557,426 No
2021-05-12 Zanganeh Maky Chief Operating Officer Buy 389,077 $5.24 $2,038,763 No
2020-11-30 Powell David Jonathan Chief Scientific Officer Sell 43,282 $4.41 $190,694 Yes
2020-11-25 Powell David Jonathan Chief Scientific Officer Sell 30,431 $4.30 $130,770 Yes
2020-11-06 DUGGAN ROBERT W Chief Executive Officer Buy 14,071,856 $3.34 $46,999,999 No

Insider Smart

SIMON PROPERTY GROUP (SPG) - Bottom fishing the crash could be intimidating, but it can be easier if you know insiders are on your side. Aeppel Glyn, Director of SPG played safe and bought shares in May at $50, but it is not late at all, the stock is now $90.

Insider Smart

CARNIVAL CORP (CCL) - Cruislines $CCL $NCLH $RCL took a huge beat due to the pandemic, concerns of bankruptcy were raised. Among the three dominating companies in the industry, $CCL is the first one bought by insiders, such a bold move would definitely boost investor confidence.